NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity.

Jürg P F Nüesch, Jean Rommelaere
Author Information
  1. Jürg P F Nüesch: Program Infection and Cancer, Abt. F010 and INSERM U701, Deutsches Krebsforschungszentrum, Heidelberg, Germany. jpf.nuesch@dkfz-heidelberg.de

Abstract

During a productive infection, the prototype strain of the parvovirus minute virus of mice (MVMp) induces dramatic morphological alterations in permissive A9 fibroblasts, culminating in cell lysis at the end of infection. These cytopathic effects (CPE) result from rearrangements and destruction of the cytoskeletal micro- and intermediate filaments, while other structures such as the nuclear lamina and particularly the microtubule network remain protected throughout the infection (J. P. F. Nüesch et al., Virology 331:159-174, 2005). In order to unravel the mechanism(s) by which parvoviruses trigger CPE, we searched for NS1 interaction partners by differential affinity chromatography, using distinct NS1 mutants debilitated specifically for this function. Thereby, we isolated an NS1 partner polypeptide, whose interaction with NS1 correlated with the competence of the viral product for CPE induction, and further identified it by tandem mass spectrometry and Western blotting analyses to consist of the catalytic subunit of casein kinase II, CKIIalpha. This interaction of NS1 with CKIIalpha suggested interference by the viral protein with intracellular signaling. Using permanent cell lines expressing dominant-negative CKIIalpha mutants, we were able to show that this kinase activity was indeed specifically involved in parvoviral CPE and progeny particle release. Furthermore, the NS1/CKIIalpha complex proved to be able to specifically phosphorylate viral capsids, indicating a mediator function of NS1 for CKII activity and specificity, at least in vitro. Altogether our data suggest that parvovirus-induced CPE is mediated by NS1 interference with intracellular CKII signaling.

References

  1. J Virol. 1983 Jun;46(3):944-55 [PMID: 6602222]
  2. Cell Growth Differ. 1995 Jul;6(7):781-7 [PMID: 7547499]
  3. J Virol. 2004 Oct;78(19):10685-94 [PMID: 15367635]
  4. J Cell Biol. 2001 Mar 19;152(6):1183-96 [PMID: 11257119]
  5. Adv Virus Res. 1987;33:91-174 [PMID: 3296697]
  6. J Virol. 2003 Jan;77(1):433-42 [PMID: 12477848]
  7. J Virol. 1998 Dec;72(12):9966-77 [PMID: 9811734]
  8. EMBO J. 1990 Sep;9(9):2989-95 [PMID: 2167840]
  9. J Virol. 1997 Jun;71(6):4671-8 [PMID: 9151861]
  10. J Virol. 2001 May;75(9):4394-8 [PMID: 11287588]
  11. J Virol. 1997 Aug;71(8):5733-41 [PMID: 9223459]
  12. J Virol. 2000 Dec;74(23):10892-902 [PMID: 11069983]
  13. J Virol. 2001 Jul;75(13):5730-9 [PMID: 11390575]
  14. Virology. 1992 Nov;191(1):406-16 [PMID: 1413512]
  15. Mol Cell Biol. 1995 Jan;15(1):524-33 [PMID: 7799962]
  16. J Virol. 1990 Oct;64(10):4654-60 [PMID: 2144594]
  17. J Virol. 1999 Sep;73(9):7410-20 [PMID: 10438831]
  18. J Virol. 2003 Jul;77(14):8048-60 [PMID: 12829844]
  19. J Virol. 2000 May;74(10):4807-15 [PMID: 10775619]
  20. Chin J Dig Dis. 2005;6(2):72-81 [PMID: 15904425]
  21. J Virol. 1992 Oct;66(10):5705-13 [PMID: 1388209]
  22. J Virol. 2001 Nov;75(22):11071-8 [PMID: 11602746]
  23. Nature. 1990 Nov 1;348(6296):91-2 [PMID: 2234068]
  24. J Virol. 1997 Jul;71(7):5323-9 [PMID: 9188601]
  25. J Virol. 2002 Jul;76(13):6518-31 [PMID: 12050365]
  26. J Virol. 1998 May;72(5):4149-56 [PMID: 9557704]
  27. J Virol. 1994 Oct;68(10):6446-53 [PMID: 8083981]
  28. J Virol. 1988 Mar;62(3):851-60 [PMID: 3339715]
  29. J Virol. 1998 Oct;72(10):8002-12 [PMID: 9733839]
  30. J Virol. 2003 Dec;77(23):12466-78 [PMID: 14610171]
  31. Virology. 2005 Jan 5;331(1):159-74 [PMID: 15582663]
  32. Virology. 1993 Oct;196(2):637-51 [PMID: 8372437]
  33. Virology. 1999 Jul 5;259(2):402-15 [PMID: 10388664]
  34. J Virol. 2002 Oct;76(20):10307-19 [PMID: 12239307]
  35. Virology. 1995 May 10;209(1):122-35 [PMID: 7747462]
  36. Virology. 2000 Dec 5;278(1):151-67 [PMID: 11112491]
  37. Virology. 1998 Jan 20;240(2):326-37 [PMID: 9454706]

MeSH Term

Amino Acid Sequence
Animals
Base Sequence
Capsid Proteins
Casein Kinase II
Cytopathogenic Effect, Viral
Cytotoxicity, Immunologic
Fluorescent Antibody Technique
HeLa Cells
Humans
Intracellular Fluid
Mice
Minute Virus of Mice
Molecular Sequence Data
Phosphorylation
Signal Transduction
Viral Nonstructural Proteins

Chemicals

Capsid Proteins
NS1 protein, parvovirus
Viral Nonstructural Proteins
Casein Kinase II

Word Cloud

Created with Highcharts 10.0.0NS1CPEinteractioninfectionspecificallyviralCKIIalphaCKIIcellmutantsfunctionkinaseinterferenceproteinintracellularsignalingableactivitycomplexparvovirus-inducedproductiveprototypestrainparvovirusminutevirusmiceMVMpinducesdramaticmorphologicalalterationspermissiveA9fibroblastsculminatinglysisendcytopathiceffectsresultrearrangementsdestructioncytoskeletalmicro-intermediatefilamentsstructuresnuclearlaminaparticularlymicrotubulenetworkremainprotectedthroughoutJPFNüeschetalVirology331:159-1742005orderunravelmechanismsparvovirusestriggersearchedpartnersdifferentialaffinitychromatographyusingdistinctdebilitatedTherebyisolatedpartnerpolypeptidewhosecorrelatedcompetenceproductinductionidentifiedtandemmassspectrometryWesternblottinganalysesconsistcatalyticsubunitcaseinIIsuggestedUsingpermanentlinesexpressingdominant-negativeshowindeedinvolvedparvoviralprogenyparticlereleaseFurthermoreNS1/CKIIalphaprovedphosphorylatecapsidsindicatingmediatorspecificityleastvitroAltogetherdatasuggestmediatedalpha:novelmediatingcytotoxicity

Similar Articles

Cited By